Cargando…

Timing of SGLT2i initiation after acute myocardial infarction

BACKGROUND: Pharmacological post-MI treatment is routinely initiated at intensive/cardiac care units. However, solid evidence for an early start of these therapies is only available for dual platelet therapy and statins, whereas data on beta blockers and RAAS inhibitors are heterogenous and mainly l...

Descripción completa

Detalles Bibliográficos
Autores principales:	von Lewinski, Dirk, Kolesnik, Ewald, Aziz, Faisal, Benedikt, Martin, Tripolt, Norbert J., Wallner, Markus, Pferschy, Peter N., von Lewinski, Friederike, Schwegel, Nora, Holman, Rury R., Oulhaj, Abderrahim, Moertl, Deddo, Siller-Matula, Jolanta, Sourij, Harald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544140/ https://www.ncbi.nlm.nih.gov/pubmed/37777743 http://dx.doi.org/10.1186/s12933-023-02000-5

Ejemplares similares

Impact of the SGLT2-inhibitor empagliflozin on inflammatory biomarkers after acute myocardial infarction – a post-hoc analysis of the EMMY trial
por: Benedikt, Martin, et al.
Publicado: (2023)

Empagliflozin in acute myocardial infarction: the EMMY trial( )
por: von Lewinski, Dirk, et al.
Publicado: (2022)

SGLT2 Inhibitors and Their Antiarrhythmic Properties
por: Kolesnik, Ewald, et al.
Publicado: (2022)

Alterations in trimethylamine-N-oxide in response to Empagliflozin therapy: a secondary analysis of the EMMY trial
por: Aziz, Faisal, et al.
Publicado: (2023)

New Antihyperglycemic Drugs and Heart Failure: Synopsis of Basic and Clinical Data
por: von Lewinski, Dirk, et al.
Publicado: (2017)

Characterization of the SGLT2 Interaction Network and Its Regulation by SGLT2 Inhibitors: A Bioinformatic Analysis
por: Wicik, Zofia, et al.
Publicado: (2022)

Simplified Acute Physiology Score 3 Performance in Austrian COVID-19 Patients Admitted to Intensive Care Units with and without Diabetes
por: Aziz, Faisal, et al.
Publicado: (2022)

Cardiovascular Outcome in Patients Treated With SGLT2 Inhibitors for Heart Failure: A Meta-Analysis
por: Gager, Gloria M., et al.
Publicado: (2021)

Incidence, predictors, and prognosis of premature discontinuation or switch of prasugrel or ticagrelor: the ATLANTIS - SWITCH study
por: Winter, Max-Paul, et al.
Publicado: (2019)

Alteration of circulating platelet-related and diabetes-related microRNAs in individuals with type 2 diabetes mellitus: a stepwise hypoglycaemic clamp study
por: Eyileten, Ceren, et al.
Publicado: (2022)

Platelet reactivity patterns in patients treated with dual antiplatelet therapy
por: Winter, Max‐Paul, et al.
Publicado: (2019)

Ticagrelor and prasugrel are independent predictors of improved long‐term survival in ACS patients
por: Gager, Gloria M., et al.
Publicado: (2020)

Thermic sealing in femoral catheterization: First experience with the Secure Device
por: Sacherer, Michael, et al.
Publicado: (2019)

INTERmittent FASTing in people with insulin‐treated type 2 diabetes mellitus – the INTERFAST‐2 study protocol
por: Obermayer, Anna, et al.
Publicado: (2022)

Revisiting the Diabetes-Heart Failure Connection
por: Wallner, Markus, et al.
Publicado: (2018)

Cangrelor Induces More Potent Platelet Inhibition without Increasing Bleeding in Resuscitated Patients
por: Prüller, Florian, et al.
Publicado: (2018)

Efficacy and Safety of Intermittent Fasting in People With Insulin-Treated Type 2 Diabetes (INTERFAST-2)—A Randomized Controlled Trial
por: Obermayer, Anna, et al.
Publicado: (2023)

Diabetic Cardiomyopathy: Current and Future Therapies. Beyond Glycemic Control
por: Borghetti, Giulia, et al.
Publicado: (2018)

Hypoglycaemia leads to a delayed increase in platelet and coagulation activation markers in people with type 2 diabetes treated with metformin only: Results from a stepwise hypoglycaemic clamp study
por: Aberer, Felix, et al.
Publicado: (2019)

The Anti-Cancer Multikinase Inhibitor Sorafenib Impairs Cardiac Contractility by Reducing Phospholamban Phosphorylation and Sarcoplasmic Calcium Transients
por: Schneider, Christopher, et al.
Publicado: (2018)

Outcomes of ECLS-SHOCK Eligibility Criteria Applied to a Real-World Cohort
por: von Lewinski, Dirk, et al.
Publicado: (2023)

Agreement between cardiovascular disease risk assessment tools: An application to the United Arab Emirates population
por: Oulhaj, Abderrahim, et al.
Publicado: (2020)

A biopsychosocial model of severe fear of COVID-19
por: Nürnberger, Patrick, et al.
Publicado: (2022)

Performance of the Intermittently Scanned Continuous Glucose Monitoring (isCGM) System during a High Oral Glucose Challenge in Adults with Type 1 Diabetes—A Prospective Secondary Outcome Analysis
por: Moser, Othmar, et al.
Publicado: (2021)

Glucose Metabolism and Metabolomic Changes in Response to Prolonged Fasting in Individuals with Obesity, Type 2 Diabetes and Non-Obese People—A Cohort Trial
por: Tripolt, Norbert J., et al.
Publicado: (2023)

Disease management programs in heart failure: half a century of an unmet need
por: Moertl, Deddo
Publicado: (2017)

COVID-19 In-Hospital Mortality in People with Diabetes Is Driven by Comorbidities and Age—Propensity Score-Matched Analysis of Austrian National Public Health Institute Data
por: Aziz, Faisal, et al.
Publicado: (2021)

Changes in Lipoprotein(a) Levels in People after ST Elevation Myocardial Infarction—The STEMI-Lipids Study
por: Sourij, Caren, et al.
Publicado: (2023)

Intermittent Fasting (Alternate Day Fasting) in Healthy, Non-obese Adults: Protocol for a Cohort Trial with an Embedded Randomized Controlled Pilot Trial
por: Tripolt, Norbert J., et al.
Publicado: (2018)

Heart rate-reducing therapy with add-on ivabradine and bisoprolol before coronary computed tomographic angiography in a fast-track ambulatory setting
por: Muster, Viktoria, et al.
Publicado: (2018)

Impaired aspirin-mediated platelet function inhibition in resuscitated patients with acute myocardial infarction treated with therapeutic hypothermia: a prospective, observational, non-randomized single-centre study
por: Prüller, Florian, et al.
Publicado: (2018)

Rapid glucose rise reduces heart rate variability in adults with type 1 diabetes: A prospective secondary outcome analysis
por: Eckstein, Max L., et al.
Publicado: (2021)

Istaroxime, a potential anticancer drug in prostate cancer, exerts beneficial functional effects in healthy and diseased human myocardium
por: Wallner, Markus, et al.
Publicado: (2017)

Blood levels of microRNAs associated with ischemic heart disease differ between Austrians and Japanese: a pilot study
por: Wakabayashi, Ichiro, et al.
Publicado: (2020)

EndoBarrier™ Implantation Rapidly Improves Insulin Sensitivity in Obese Individuals with Type 2 Diabetes Mellitus
por: Obermayer, Anna, et al.
Publicado: (2021)

COVID‐19 fatality prediction in people with diabetes and prediabetes using a simple score upon hospital admission
por: Sourij, Harald, et al.
Publicado: (2020)

miR-1183 Is a Key Marker of Remodeling upon Stretch and Tachycardia in Human Myocardium
por: Djalinac, Natasa, et al.
Publicado: (2022)

Improved glycaemic variability and basal insulin dose reduction during a running competition in recreationally active adults with type 1 diabetes—A single-centre, prospective, controlled observational study
por: Moser, Othmar, et al.
Publicado: (2020)

The role of stretch, tachycardia and sodium‐calcium exchanger in induction of early cardiac remodelling
por: Djalinac, Natasa, et al.
Publicado: (2020)

Impairment of brainstem implicit learning paradigms differentiates multiple system atrophy (MSA) from idiopathic Parkinson syndrome
por: von Lewinski, Friederike, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ho9gnq1d0ps3q629g5ga1rpq7r